Increased total 7α-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 53, Issue 2, 1998, Pages

  Attal Khémis, Sandrine ^a   Dalmeyda, Vincent ^a   Michot, Jean Luc ^b   Roudier, Michel ^b,c   Morfin, Robert ^a  

^a École Supérieure d Ingénieurs Géomètres Topographes   (France)

^b INSERM   (France)

^c Hopital Charles Richet   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA HYDROXYPRASTERONE; PRASTERONE; PRASTERONE SULFATE; STEROID HORMONE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; STEROID BLOOD LEVEL; STEROID METABOLISM;

EID: 0031943120     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/53A.2.B125     Document Type: Article

References (7)

1. Watson RR, Huls A, Araghinikuam M, Chung S. Dehydroepiandrosterone and diseases of aging. Drug Aging. 1996;9:274-291.
2. Andrási E, Farkas E, Scheibler H, Reffy A, Bezúr L. Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Arch Gerontol Geriat. 1995;21:89-97.
3. Farrar LA, Cupples LA, VanDuijn CM, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol. 1995;38:797-808.
4. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol. 1995;26:816-823.
5. Smale G, Nichols NR, Brady DR, Finch CE, Walter E, Horton JR. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol. 1995;133:225-230.
6. Levy-Lahad E, Bird TD. Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol. 1996;40:829-840.
7. Roses AD. The Alzheimer's diseases. Curr Opin Neurol. 1996;6:644-650.